News Archive - Bristows

VIEW:

CJEU Judgment in European Superleague Case has Significant Implications That Go Beyond Football

Stephen Smith, Sean-Paul Brankin and Matthew Hunt explore the CJEU's Judgment in European Superleague Case

CJEU Judgment in European Superleague Case has Significant Implications That Go Beyond Football

18.04.2024

Podcast: Automated Decision-Making

07.02.2024

Implementation deadlines for the EU In Vitro Diagnostic Medical Device Regulation further postponed

29.01.2024

Bristows enhances its world class patent litigation practice in Life Sciences and Technology with the promotion of two new partners

29.01.2024

UK MDR: further delays, unexpected developments?

23.01.2024

Competition Law Focus on Healthcare Markets Continues with Welcome (but Limited) CMA Guidance on Collaboration for Combination Therapies

06.12.2023

Competition Law Focus on Healthcare Markets Continues with Welcome (but Limited) CMA Guidance on Collaboration for Combination Therapies

06.12.2023

The Court of Appeal confirms English courts can force parties into ADR

01.12.2023

Stephen Smith quoted in Global Competition Review

28.11.2023

AI’s emerging role in cancer diagnosis

24.11.2023

Autumn Statement 2023: key business tax announcements

22.11.2023

Tax Briefing: the Supreme Court’s decisive ruling in HMRC v Vermilion Holdings

17.11.2023

Human embryo research: should we re-draw the line?

09.11.2023

Instagram v Meta 404: Not for the GRAM

09.11.2023

Stephen Smith quoted in The Times

20.10.2023

GRUR Patent’s August 2023 edition on Plausibility in the UK following Sandoz and Teva v BMS

02.10.2023

Naked and Afraid: Intel re-fined €376.3m for naked restrictions

29.09.2023

Victoria Yuan quoted in Equity Report on Optum/EMIS

29.09.2023

Stephen Smith quoted in Global Competition Review

29.09.2023

Every Lidl helps: competition in the groceries sector

21.09.2023

‘Tuna bonds’ in Mozambique – Important arbitration decision from the Supreme Court on the proper approach to s.9 of the Arbitration Act 1996

21.09.2023

Will Microsoft’s call of duty to restructure Activision deal pay off?

21.09.2023

The Innovative Devices Access Pathway – expediting access to MedTech

20.09.2023

First CRISPR therapy seeks regulatory approval, but will it be able to avoid the pitfalls of other cell and gene therapies?

18.09.2023

Bristows opens Dublin office

04.09.2023

Sham litigation meets competitor denigration: Italian competition authority fines Roxtec for abuse of dominance

01.09.2023

Bristows appoints Adrian Sim as new Joint Managing Partner

01.09.2023

Can your DPO also act as ‘Senior Responsible Individual’ under the proposed UK Data Protection Bill?

30.08.2023

ATVI/MSFT: Victoria Yuan quoted in CTFN

24.08.2023

A deep dive on new UK post-market surveillance rules

23.08.2023

Team NB adopts template tripartite agreement for legacy medical devices

18.08.2023

New UK Approved Bodies appointed for medical devices

17.08.2023

Royalty payments in patent licensing

16.08.2023

Proposed review of the statutory scheme: a sign of things to come in VPAS?

15.08.2023

LexisNexis webinar: The future of cookie pop-ups

14.08.2023

Is the end near for UKCA marks for medical devices?

14.08.2023

Sophie Lawrance quoted in Global Competition Review

10.08.2023

Sophie Lawrance quoted in The Times

09.08.2023

ATVI/MSFT: Stephen Smith and Victoria Yuan quoted in CTFN

02.08.2023

Joe Sako Summer Workshop 2023

31.07.2023

Medicines aspects of Windsor Framework to commence in 2025

26.06.2023

Stephen Smith quoted in Global Competition Review

23.06.2023

The present and future of SESG for biopharmaceutical companies

16.06.2023

The New EU R&D Block Exemption and Guidelines – A Partial Win for Innovation!

16.06.2023

CLIP of the month: New frontiers for assessing digital mergers. Boldly going where competition authorities have not (quite!) gone before

08.06.2023

Victoria Yuan quoted in Equity Report

05.06.2023

Proposal for a Regulation for substances of human origin

24.05.2023

UK MDR amending legislation heralds arrival of new medical device framework

24.05.2023

Sophie Lawrance quoted in Global Competition Review

22.05.2023

Open source and sustainability – where’s the gap?

16.05.2023

Sophie Lawrance quoted in Global Competition Review

11.05.2023

Re-packaging of parallel traded medicinal products

10.05.2023

Bristows and KPMG co-publish whitepaper on sourcing agile services to deliver digital transformations

04.05.2023

DNA sequencing by synthesis patents held valid and infringed

03.05.2023

The Digital Markets, Competition and Consumers Bill: 10 things you need to know

02.05.2023

Bristows is delighted to announce the promotion of three new partners

02.05.2023

CLIP of the month: European Commission draft regulation on SEPs – simplifying or muddling FRAND licensing?

28.04.2023

Bristows acts in leading trade mark case

27.04.2023

Reasons to be optimistic in 2023

26.04.2023

Latest Bristows’ SnippITs article re-published by LexisNexis

25.04.2023

Under the antitrust spotlight: (mis)use of patents in the pharma sector

12.04.2023

Updates to EU and UK competition authority guidance – why the biopharma sector should sit up and take note

05.04.2023

Artificial intelligence: Risks in recruitment

04.04.2023

Arrow declarations – is there a limit to their availability?

29.03.2023

Will we ever see a UKCA mark for medical devices?

28.03.2023

An inside job – how clinical reality can shape the medicines market

22.03.2023

MDR and IVDR amending Regulation comes into force

21.03.2023

mRNA patent litigation…the new patent wars?

16.03.2023

A brave new world for the regulation of medicines, devices and IVDs in the UK

16.03.2023

Unified Patent Court: state of play and what biotech companies can do to prepare now

08.03.2023

EU and UK reach new agreement on medicines regulation in Northern Ireland

07.03.2023

CLIP of the month: Curb your enthusiasm! CMA’s extra-territorial investigatory powers grind to a halt

23.02.2023

Sophie Lawrance and Edwin Bond’s article published in Competition Law Journal

15.02.2023

2022: a big year for R&D tax relief

13.02.2023

EU and UK competition law expert, Sophie Lawrance, quoted in Global Competition Review

06.02.2023

Bristows reappointed to NHS legal panel

02.02.2023

IP experts, Andrew Bowler and Sean Ibbetson, share their end of year reviews with LexisNexis

11.01.2023

A UK Technology Transfer Block Exemption Order? What the biopharmaceutical industry may have to say in relation to the CMA’s forthcoming consultation

11.01.2023

MDR and IVDR transition extension: European Commission publishes amendment Regulation

10.01.2023

Analysis: Are your agreements ready for the UPC?

22.12.2022

A perspective on Mark Watts’ career, in Legal Business

09.12.2022

From startups to tech giants – Bristows lawyers talk to Legal Business about the players in the tech industry

09.12.2022

Myles Jelf comments on the UPC’s case management system testing phase

02.12.2022

CLIP of the month: The new EC Notice on Market Definition addresses approaches to two-sided platforms, digital ecosystems and pharma

01.12.2022

European Commissioner Kyriakides hints at decisive action on EU MDR transition period

28.11.2022

VPAS repayments continue to cause concern

18.11.2022

UK government publishes guidance on examining patent applications relating to artificial intelligence

17.11.2022

The AI Liability Directive

17.11.2022

Toby Crick co-authors OpenUK’s book on the legal issues of open technology

10.11.2022

Sophie Lawrance and Luke Maunder talk to MIP about Optis v Apple

09.11.2022

CLIP of the month: Can abuse of dominance rules apply when merger control rules do not?

08.11.2022

Financial regulation in the metaverse

08.11.2022

Myles Jelf comments on the UPC Rules of Procedure changes

07.11.2022

Matt Raynor talks to IAM about the importance of English litigation

04.11.2022

Cloud services in the competition law spotlight

31.10.2022

With great fanfare, the MHRA publishes roadmap for future regulation of software and AI medical devices

26.10.2022

MHRA postpones new UK medical devices regulatory framework by 12 months

24.10.2022

More MDR Notified Bodies, IVDR lags behind – but is help on the way?

24.10.2022

Lexis Nexis hosts article by our life sciences regulatory expert on UK blood, tissues and cells law

20.10.2022

Myles Jelf’s UPC insights reported by Managing IP

19.10.2022

Competition/ antitrust in the metaverse

13.10.2022

Bristows acts on agreement to acquire Airtel-Vodafone

11.10.2022

Compulsory patent licensing – developments in China analysed

11.10.2022

Patent litigator Charlie French is a WIPR trailblazers for 2022

07.10.2022

Bristows acts on sale of Intelligent Fingerprinting to GBS

07.10.2022

Brexit impact delayed: MHRA announces extension to the European Commission Decision Reliance Procedure

06.10.2022

Bristows appoints Stephen Smith as new Joint Managing Partner

04.10.2022

Ofcom homes in on digital markets

29.09.2022

mRNA Vaccines: a growing and complex IP landscape

28.09.2022

CLIP of the month: The Digital Markets Act and the designation of gatekeepers

28.09.2022

VPAS or the Statutory Scheme: stick or twist?

26.09.2022

The importance of pandemic preparedness

26.09.2022

MDCG releases guidance on addressing lack of Notified Body capacity

22.09.2022

VPAS – If you thought 15% was a shock, get ready for 30%!

21.09.2022

MHRA designates fourth UK Approved Body for medical devices

21.09.2022

The DMA: Challenges for the regulator as well as the regulated

14.09.2022

A sleight mistake: Magic goes wrong in the new Precision Breeding Bill

14.09.2022

Bristows’ article series on mRNA referenced by Managing IP

13.09.2022

Regulator says your technical non-compliance isn’t a problem? Think again

08.09.2022

Mark Watts writes for PLC Magazine, discussing how law and regulation may benefit the metaverse

01.09.2022

Sophie Lawrance and Manon Rattle assess a recent Court of Appeal judgment against Pfizer and Flynn for the Solicitors Journal

31.08.2022

RPM conduct: Global Competition Review quotes competition specialist Sean-Paul Brankin

11.08.2022

What’s wrong with having lots of patents? Humira ‘patent thicket’ survives antitrust challenge

08.08.2022

Royalty Pharma Collection Trust v Boehringer Ingelheim GmbH

05.08.2022

Shroom boom – are psychedelics a new frontier in mental healthcare?

03.08.2022

The NS&I Act and the Advanced Materials sector

01.08.2022

University spinouts

01.08.2022

Competition law specialist Sophie Lawrance quoted in Global Competition Review

26.07.2022

Myles Jelf talks about the UPC case management software with Managing IP

21.07.2022

CLIP of the month: Patent settlements and antitrust in PRC

19.07.2022

Nokia v Oppo in the Court of Appeal – the ‘FRAND elephant’ in the room (and coming soon to a court near you…)

12.07.2022

LSIPR: Sophie Lawrance and James Batsford write about the Supreme Courts decision on cost award exemptions for public bodies

12.07.2022

Bristows IP litigation experts quoted in Managing IP

06.07.2022

Sophie Lawrance quoted in PaRR Global

05.07.2022

Vik Khurana writes about the NS&I Act and the computing hardware sector for the Solicitors Journal

30.06.2022

Bristows UPC experts quoted in Managing IP

27.06.2022

Regulatory T cells: the next wave of cell therapy

21.06.2022

The UPC is nigh – how should life sciences companies prepare?

20.06.2022

Cell therapies: an introduction

16.06.2022

Dominic Adair is quoted in Managing IP

16.06.2022

Q&A – The industry perspective

14.06.2022

MDR/IVDR update – sympathy, but no relief

14.06.2022

A 30th Notified Body for MDR

14.06.2022

AI and patentable inventions – what now?

09.06.2022

Ralph Giles on forthcoming changes to Modern Slavery statements

08.06.2022

How are regulators thinking about AI in medicines regulation?

07.06.2022

CLIP of the month: The rise of the anti-suit injunction: tackling the latest challenge in FRAND disputes

06.06.2022

AI Summit: What the speakers learned

31.05.2022

Spotlight on IVDR – The European Union’s new In Vitro Diagnostic Medical Device Regulation is here

27.05.2022

The transformative potential of AI in clinical trials

26.05.2022

Public bodies are not exempt from paying successful appellants’ costs, UKSC rules

26.05.2022

The start of Golden Age? The rise of private equity

24.05.2022

Spotlight on IVDR – Will the European Commission blink?

23.05.2022

Ethereum’s move to Proof of Stake and its environmental impact

23.05.2022

The MDR has a new Notified Body – Na Zdrowie!

20.05.2022

UK Biotech a mirror of the US market

18.05.2022

Spotlight on IVDR — Circumventing the Notified Body bottleneck

17.05.2022

Sarah Hill explains why sustainability and ESG issues matter to SCL

16.05.2022

One patent court to rule them all?

12.05.2022

Spotlight on IVDR – Why we keep banging on about Notified Bodies

12.05.2022

Spotlight on IVDR – Cheers Slovakia! Seventh Notified Body designated under IVDR

09.05.2022

Bristows elects dual-qualified Xisca Borrás to the firm’s partnership, strengthening its life sciences regulatory practice

09.05.2022

Global Competition Review quotes Bristows partner and competition law specialist Sophie Lawrance

05.05.2022

Updates to the blood, tissues and cells legislation

04.05.2022

CLIP of the month: Oxera study warns against heavy-handed regulation of digital platforms

03.05.2022

National Security and Investment Act: Impact on the Life Sciences sector

28.04.2022

Looking ahead to the EU In Vitro Diagnostic Medical Device Regulation

26.04.2022

Pharma beware: EU consults on tighter rules for joint innovation

20.04.2022

Why is anonymisation an important topic when using genomic data in scientific research?

20.04.2022

Myles Jelf talks about FRAND with IAM

19.04.2022

Releasing the Therapeutic GMO

14.04.2022

What will the European framework for orphan medicinal products look like in the future?

12.04.2022

Making a Bad Situation Worse? Proposed Changes to the EU R&D Block Exemption and Guidelines

08.04.2022

‘Full throttle’: venture capital in 2021

07.04.2022

Pricing of branded medicines: Amendments to the Statutory Scheme

06.04.2022

Viral vectors: shortages and innovation

30.03.2022

CLIP of the month: EC publishes draft new Horizontal Guidelines – three steps back (and one forward?)

30.03.2022

Myles Jelf talks about the UPC with Managing IP

24.03.2022

The new UK MDR draws near, and we’re all still clueless about the rules

24.03.2022

A Franco-German clarion call to ease the burden of the MDR and IVDR

23.03.2022

EU and UK competition law specialist, Stephen Smith, quoted in Global Competition Review

15.03.2022

Bristows partner Stephen Smith quoted in Global Competition Review

14.03.2022

They are out to get you

08.03.2022

Bristows supports women with new initiatives to help employees and their families

08.03.2022

Lawfully running a red light: aneuploidy testing

07.03.2022

MHRA gets our hopes up for new UK Approved Bodies

07.03.2022

Autumn Budget 2021 and a new age of optimism: changes to the UK’s R&D tax relief regime

02.03.2022

Non-fungible tokens (NFTs) and brand protection in the UK

28.02.2022

Is another intellectual property specialist required at the UK Supreme Court? Andrew Bowler quoted in Managing IP Magazine

23.02.2022

Don’t mess with the NHS: CMA issues £35m fine for pay-for-delay agreements concerning anti-nausea drug

23.02.2022

European Commission consults on draft common specifications for certain high-risk in vitro diagnostic medical devices

22.02.2022

AI – commercial models and value recognition in life sciences transactions

22.02.2022

JD Sports and Footasylum merger: Sean-Paul Brankin quoted in Global Competition Review

18.02.2022

CLIP of the month: AG Rantos abuse of dominance

14.02.2022

VPAS: One-off repayment rate for 2022 announced

11.02.2022

IAB Europe’s Transparency & Consent Framework does not comply with the GDPR

10.02.2022

Exhaustion of intellectual property rights in the UK post-Brexit – asymmetry to continue indefinitely

01.02.2022

Five Life Sciences trends for 2022

31.01.2022

Bristows partner Sophie Lawrance quoted in Global Competition Review

19.01.2022

The Fashion Law quotes our trademark team on exhaustion

07.01.2022

Updated CMA merger guidance as NSI Act comes into force

07.01.2022

Legal Cheek survey results show Bristows at the top for peer support and partner approachability

06.01.2022

Supply of medicines in Northern Ireland: the EC and UK come closer to a solution

22.12.2021

Charlie Hawes speaks about AI to IBA’s In-House Perspective magazine

17.12.2021

Bloomberg Law quotes Sophie Lawrance, Bristows partner and competition law expert

17.12.2021

Andrew Bowler quoted in the Law Society Gazette

16.12.2021

Sarah Hill introduces new sustainability SCL group

14.12.2021

Bristows acts on landmark movie deal with Disney+

10.12.2021

Bristows acts on Series A Financing of AviadoBio

09.12.2021

Julia Cockroft quoted in LexisNexis

09.12.2021

Seminar: “Trust me, I am an algorithm.” Is AI the future of healthcare?

09.12.2021

“It’s in the game” – the rise of in-gaming advertising

03.12.2021

CLIP of the month: safeguarding pro-competitive collaborations in the life sciences sector

03.12.2021

Ketian v Hitachi: China’s first compulsory licence?

25.11.2021

Car charging market: Stephen Smith quoted in Global Competition Review

23.11.2021

Bristows wins the British Legal Award for Life Sciences Team of the Year 2021

18.11.2021

Bristows mentioned in Legal Business as one of the strongest disputes and tech firms

15.11.2021

Gareth Wadley joins Bristows as new head of employment team

08.11.2021

Sophie Lawrance, EU and UK competition law specialist, quoted in Global Competition Review

05.11.2021

Advertising medicines and medical devices in the UK: Who’s who?

05.11.2021

What’s the wait? – Number of MDR and IVDR notified bodies remains stubbornly low

01.11.2021

CLIP of the month: patent pledges and EU competition law

01.11.2021

Spotlight on mRNA – Regulation of mRNA vaccines and therapies

28.10.2021

Juve Patent reports on Bristows and Teva’s court victory

22.10.2021

Alex Denoon MedTech summit talk mentioned by MedTech Insight

22.10.2021

EC proposals for Northern Ireland: A way forward for medicines?

22.10.2021

Spotlight on mRNA – Recent deal activity

21.10.2021

Hallelujah! Plans to extend IVDR transitional period announced

18.10.2021

Going live – New rules on publication of clinical trials results-related information under the EU Clinical Trials Regulation

13.10.2021

What’s new in the future UK regulation of medical devices?

13.10.2021

Illumina/Grail: bio-tech companies in the firing line as the European Commission expands the limits of European merger control

13.10.2021

Spotlight on mRNA – IP landscape

08.10.2021

Bristows’ survey on public trust in AI is mentioned in AI Magazine

07.10.2021

CLIP of the month: the end of most favoured nation clauses?

06.10.2021

What does “quality” mean when it comes to online advertising?

05.10.2021

Sustainable cooperation: Green Deal Policy Brief reflects European Commission’s drive for environmentally-friendly innovation

04.10.2021

Andrew Bowler is quoted in Managing IP on Judge Meade’s first year in court

28.09.2021

Spotlight on mRNA – What is mRNA and what can it be used for?

24.09.2021

Spotlight on mRNA – A brief history of mRNA research

24.09.2021

Consultation on the future of medical device regulation opens

21.09.2021

IVDR Notified Bodies – here comes the crunch

16.09.2021

MDR Notified Bodies – the stroll-out continues

16.09.2021

“An error of principle and approach” – Birss LJ clarifies the law on breadth of claim and uncertainty insufficiency

16.09.2021

JD sports and Footasylum merger: Stephen Smith quoted in Global Competition Review

13.09.2021

Hannah Crowther wins UK Rising Star title for the second time

10.09.2021

Bristows spotlighted in Legal Business’ feature on intellectual property

02.09.2021

Liz Cohen and other women in legal management interviewed by Legal Business

02.09.2021

Robert Bond comments on potential divergence from GDPR on DataIQ

02.09.2021

Andy Bowler quoted on WIPR about the UPC legislation published by Germany

02.09.2021

CLIP of the month: the European Commission draft revised Vertical Guidelines – no agency protection for online platforms

01.09.2021

Bio-Science Law Review includes Sophie Lawrance and Sean-Paul Brankin’s article

25.08.2021

Transforming public procurement – goodbye red tape, hello streamlined innovation?

25.08.2021

Bristows advises WPP on its acquisition of Satalia

24.08.2021

Should the CMA investigate the music industry?

12.08.2021

EU and UK competition law specialist Sophie Lawrance quoted in Global Competition Review

10.08.2021

Bristows wins trade mark case for Glebe Farm against Oatly

05.08.2021

Jamie Witton quoted in TU Automotive

04.08.2021

Sean Ibbetson is quoted in Managing IP

04.08.2021

CLIP of the month: defining markets for Facebook and other digital platforms

02.08.2021

Naomi Hazenberg is one of the WIPR trailblazers for 2021

29.07.2021

We expanded our leading Brands, Designs & Copyright team with a lateral partner hire

27.07.2021

Alex Keenlyside quoted in IBA news analysis

27.07.2021

European Commission requires diesel car makers to clean up their act in ground-breaking punishment of technical cooperation

26.07.2021

Sophie Lawrance quoted in Bloomberg Law

23.07.2021

Brave new online world? The Commission proposes a new approach to digital platforms in the draft verticals regime

23.07.2021

WHO’s recommendations on gene editing: Julian Hitchcock comments in Nature, Science Media Centre, and Pharmazeutische Zeitung

23.07.2021

Partner Sophie Lawrance quoted in Global Competition Review

20.07.2021

Animal vaccines: COVID-19 and beyond

16.07.2021

Bristows and Privitar publish in-depth analysis of anonymisation policy in the UK

15.07.2021

Bristows assists global top-ten universities on $145 million financing for biopharmaceutical research

08.07.2021

CLIP of the month: joint technology competition policy dialogue

02.07.2021

Not just another excessive pricing case: pharma stock management in the spotlight in the Commission’s Aspen Decision

30.06.2021

US Second Circuit reverses FTC decision on online advertising restrictions

24.06.2021

The CAT’s latest Paroxetine “pay-for-delay” judgment: market definition confusion

17.06.2021

Lucie Fortune wins AIPPI UK prize 2021

16.06.2021

Cell therapies without cells?

15.06.2021

Jeremy Blum defends Glebe Farm in the IPEC against Oatly

10.06.2021

Pharma industry joins calls for delay to IVDR application date

09.06.2021

Preliminary reference round-up: Forthcoming guidance on pharma and tech disputes, and a couple of missed opportunities

09.06.2021

Team CMA: World Merger Police

04.06.2021

The modern space race: Vaccine rollout and the regulatory regime

02.06.2021

CLIP of the month: CMA and ICO unveil plans for cooperation in digital markets

01.06.2021

MHRA approves Janssen COVID-19 vaccine

01.06.2021

The Times publishes Mark Watts’ opinion in an article on data law

27.05.2021

“A career in IP” Naomi Hazenberg talks to the Law Society Gazette

27.05.2021

The small difference making big waves: Why ‘genetically engineered’ is not the same as ‘genetically modified’

27.05.2021

Horizon Europe: An update on funding for UK research and innovation post-Brexit

26.05.2021

Parallel imports: The road ahead

25.05.2021

What has changed for orphan medicinal products in the UK after Brexit?

24.05.2021

CRISPR-Cas9 – from Nobel prizes to priority

20.05.2021

Robert Bond quoted in Today’s General Counsel

19.05.2021

Another year of SPC updates: Functional claims and new therapeutic applications

18.05.2021

Bristows joins the Mindful Business Charter

13.05.2021

Paul Jordan and Sean Ibbetson quoted in The Fashion Law

13.05.2021

Data Transfers: bump or mountain in the road?

13.05.2021

EU Competitor Collaboration Rules, including R&D and Information Sharing, set to change

12.05.2021

Avoiding bias and increasing diversity in AI and health research – Part 2

12.05.2021

Avoiding bias and increasing diversity in AI and health research – Part 1

11.05.2021

EU Clinical Trials Regulation and portal expected to “go live” 31 January 2022

10.05.2021

A growing trend of smaller, early-stage investments in UK life sciences

06.05.2021

UK National Investment and Security Bill receives royal assent

06.05.2021

The Commission’s proposed Artificial Intelligence Regulation

05.05.2021

Northern Ireland and EU Medical Devices Regulation: Importer update

05.05.2021

International regulation for genome editing in 2021 and beyond

04.05.2021

CLIP of the month: Is music streaming a level playing field?

04.05.2021

Will the new pharmaceutical strategy for Europe bring changes to the biopharmaceutical rewards system?

29.04.2021

Medical Devices Regulation: UK Conformity Assessment Bodies

28.04.2021

Colin v Cuthbert: Simon Clark and Marc Linsner quoted on World IP Review

27.04.2021

Collaboration: Sustainable future or dangerous pathway?

27.04.2021

When appealing a CMA Decision can increase your penalty: the Roland appeal

27.04.2021

Simon Clark comments on the Chanel v Huawei logo dispute

23.04.2021

Biotech is in for a rollercoaster 2021

22.04.2021

Sophie Lawrance quoted in WIPR on FTC – Qualcomm antitrust suit

21.04.2021

Top 10 information sharing risks in relation to the distribution of pharmaceuticals – Lexon v CMA [2021] CAT 5

20.04.2021

CAT upholds the CMA’s nortriptyline information sharing decision – Lexon v CMA [2021] CAT 5

20.04.2021

Will Private Equity make waves in the life sciences sector in 2021?

20.04.2021

Notified Bodies – An update

20.04.2021

EU Medical Devices Regulation: Application date looms large

19.04.2021

Ground-breaking inventions: A tale of transgenic mice

15.04.2021

Brexit Britain: Dumping ground or proving ground?

13.04.2021

Paul Jordan and Andrew Butcher’s book on advertising law published

13.04.2021

UK Government’s call for views on artificial intelligence and intellectual property

13.04.2021

CLIP of the month: CMA report on algorithms and consumer harm

09.04.2021

Myles Jelf and Ben Millson comment in IP Magazine on IPCom v Vodafone

08.04.2021

Sophie Lawrance quoted in Global Competition Review

08.04.2021

Deutsche Telekom/Slovak Telekom – CJEU clarifies the scope of Bronner and the law on refusal to supply

01.04.2021

European Commission issues new medical devices software flowchart

24.03.2021

Pitfalls in negotiating and delivering digital transformation projects – a timely reminder

23.03.2021

Robert Bond shares his own history in compliance in SCCE podcast episode

19.03.2021

Patent settlement agreements and competition law – a new podcast series

19.03.2021

Ten things to think about when settling patent litigation

19.03.2021

Myles Jelf comments in World Intellectual Property Review

16.03.2021

European Commission accepts Aspen pricing commitments

15.03.2021

A US perspective – should the patent procurement process fall under the remit of antitrust law?

15.03.2021

Innovation Passports and the ILAP: A new and flexible pathway to approval

12.03.2021

Matthew Hunt quoted in Information Matters on latest Apple investigation

11.03.2021

Sophie Lawrance quoted in PaRR Global

11.03.2021

New editions of our publications launching soon

10.03.2021

Should the patent procurement process fall under the remit of antitrust law? – A US perspective

09.03.2021

AI and medical devices – Our experts answer three common questions

09.03.2021

Jerry Merton quoted on The Times’ Raconteur supplement

08.03.2021

Distributor, agent or both? The Commission’s Working Paper on “dual role” agents

03.03.2021

Myles Jelf talks to the press about the IPCOM v Vodafone appeal

02.03.2021

CLIP of the month: Competition law vs regulation in the digital space

01.03.2021

Which? takes on Qualcomm with claim for UK consumers – A guide to the legal challenges ahead

26.02.2021

OUI’s COO mentions Bristows’ role in negotiating vaccine deal on Managing IP magazine

25.02.2021

Matt Hunt quoted on the Insurance Times

25.02.2021

Medicines and Medical Devices Act 2021 and what it means for the UK regulatory landscape

18.02.2021

Aspen pricing commitments accepted by European Commission – an outlier or the ‘new normal’?

16.02.2021

Sophie Lawrance interviewed by Financier Worldwide on best practice in licensing disputes

11.02.2021

Equity stakes, revenue shares and more: how universities are deriving value from their spinouts

08.02.2021

BIA announces another record year of UK biotech investment

02.02.2021

Uncertain times: Changes to the UK’s tax regime

01.02.2021

Gaming firms fined for preventing cross-border sales

26.01.2021

Epic’s Fortnite v Apple dispute arrives in the UK

25.01.2021

AI and Life Sciences: Has protein folding been solved?

21.01.2021

Neurim and Flynn v Mylan: The price spiral argument under scrutiny

19.01.2021

Podcast on developments relating to component-level SEP licensing

19.01.2021

New year, new CMA dominance investigation…

18.01.2021

Team-NB issues a cry for help and some slight relief

13.01.2021

CLIP of the month: when does strategic patenting by pharmaceutical companies become anti-competitive?

11.01.2021

Spin-outs: What will 2021 hold for UK universities?

01.01.2021

Women in IP Leadership: Liz Cohen interviewed by the Patent Lawyer Magazine

22.12.2020

CJEU annuls Commission decision accepting Paramount commitments

22.12.2020

Back to the future? Does recent case on common law restraint of trade foreshadow how UK competition law might evolve?

18.12.2020

CJEU referral in German car litigation and EU Commission IP action plan

11.12.2020

A changing FRAND landscape?

11.12.2020

CMA issues guidance to government on new pro-competition regime

09.12.2020

MDCG releases guidance on classification rules for IVDs

08.12.2020

MedTech Europe urges European Commission to delay implementation of IVDR

08.12.2020

Number of IVDR Notified Bodies grows to five

08.12.2020

National Security and Investment Bill

02.12.2020

CLIP of the month: should agencies focus on the development of private permissioned blockchains?

01.12.2020

Custom audiences

24.11.2020

Consent Management Platforms (CMPs)

24.11.2020

Digital ad buying

24.11.2020

Not the most favoured comparison site: CMA fines Compare The Market over contract clauses

20.11.2020

Impacts of Brexit on Horizon Europe

13.11.2020

Pat Treacy and Naomi Hazenberg discuss the Unwired Planet Supreme Court ruling for IAM magazine

12.11.2020

Test and trace apps: are there any privacy impacts?

12.11.2020

Reform and the future of the Vertical Agreements Block Exemption

06.11.2020

CLIP of the month: An analysis of the CJEU’s Generics judgment

03.11.2020

Bristows gains new partner with promotion of Rachel Mumby

30.10.2020

Bristows acts on sale of Base Genomics to Exact Sciences

29.10.2020

Essential Pharma’s essential drug? CMA opens investigation into withdrawal of supply of bipolar treatment

27.10.2020

The UK’s genomic future

19.10.2020

Helicopter overview of the proposals for digital markets regulation (competition law perspective)

16.10.2020

CLIP of the month: The rise in anti-suit injunctions in global FRAND disputes

09.10.2020

What are “endeavour” clauses?

01.10.2020

Regulatory and cultural challenges for IT and outsourcing services in the healthcare and life sciences sectors

23.09.2020

Healthcare and life sciences sectors: the regulatory and cultural challenges for IT and outsourcing services

16.09.2020

Has the UK device revolution begun? The New MHRA Brexit Guidance for devices explained

09.09.2020

Medicines and Medical Devices Bill comes under scrutiny in the House of Lords

04.09.2020

New MHRA Brexit guidance…Northern Ireland FMD to come!

04.09.2020

New MHRA Brexit guidance…more to come!

02.09.2020

European Commission publishes Common Specifications for the reprocessing of single use devices

01.09.2020

CLIP of the month: Internet of Things sector inquiry

28.08.2020

UK Supreme Court approves global FRAND licences in Unwired Planet and Conversant appeals

26.08.2020

What has FRAND got to do with TV Guides?

21.08.2020

Fortnite vs. Apple

20.08.2020

Fortnite takes on Apple’s App Store in Epic antitrust battle royale

18.08.2020

Government writes to medicine suppliers requesting a six week stockpile

10.08.2020

MHRA warning about “certificates of compliance” & “Attestations of Compliance”

05.08.2020

US Department of Justice throws its weight behind SEP holders and patent pools in FRAND disputes

31.07.2020

Head of Bristows’ Brands, Designs and Copyright practice named an Appointed Person for trade mark appeals from the UKIPO

31.07.2020

CLIP of the month: The role of competition law in addressing climate change

28.07.2020

Competition authorities continue to address excessive pricing in the pharmaceutical sector

23.07.2020

SPC manufacturing waiver: UK Government responds to call for views on draft legislation to fix issues in the Waiver Regulation post-Brexit

23.07.2020

The Price is Not Right: Competition authorities continue to address excessive pricing in the pharmaceutical sector

23.07.2020

UK Government opens consultation on the power to depart from EU case law

16.07.2020

Simplicity or complexity? – A tale of two patent settlement investigations

13.07.2020

Spotlight on online platforms and digital advertising as CMA calls for a new pro-competition regulation regime

09.07.2020

Gilead’s remdesivir granted conditional Marketing Authorisation by the European Commission

03.07.2020

The Court of Appeal lets the CAT out of the costs bag…

03.07.2020

German Supreme Court upholds BKartA Facebook remedy – we “like” our new CLIP of the Month

25.06.2020

Further guidance from the Advocate General: ‘Pay-for-delay’ agreements

24.06.2020

The Schmerzgel Redemption

22.06.2020

‘Pay-for-delay’ agreements: further guidance from the Advocate General

12.06.2020

CLIP of the month: House Judiciary Inquiry into Competition in Digital Markets: Statement

05.06.2020

Back to Brexit – An update on medical devices

05.06.2020

DPN working group led by Robert Bond publishes Data Retention Guidance

04.06.2020

Cell and gene therapies

27.05.2020

26 May 2020 – a medical device milestone missed

26.05.2020

The interplay between the Clinical Trials Regulation and the GDPR

26.05.2020

The Court of Justice confirms the EMA’s approach to transparency

24.05.2020

The CMA’s director disqualification power – a power now being put to use

23.05.2020

UK government approach to COVID-19 therapeutics research

22.05.2020

The regulation of software medical devices

22.05.2020

Art.53(b) EPC exception to patentability broadened by the Enlarged Board of Appeal

20.05.2020

COVID-19: Key implications for digital transformation projects

19.05.2020

“Pay-for-delay” settlement agreements in biotech: a European perspective on the US Humira litigation

18.05.2020

High Court dismisses GSK’s claim that Sandoz’s AirFluSal Forspiro inhaler passes off GSK’s Seretide Accuhaler

17.05.2020

Using CRISPR and the implications of human genome editing

16.05.2020

Public Health England ‘approves’ Roche COVID-19 antibody test

15.05.2020

Jurisdiction challenge succeeds on appeal as contractual exclusive jurisdiction clause has priority

15.05.2020

DIY gene-editing CRISPR kits

15.05.2020

Bristows’ genome editing debate 2019: The quest for the perfect human?

13.05.2020

Pfizer v Hoffman-La Roche – evading Arrow declarations

12.05.2020

Clarity sought on plant patentability

11.05.2020

Mammoth judgment on IL-17A/F antibodies leads to patent revocation and brief SPC excursion to the CJEU

10.05.2020

Dosage regimen research; is it worth it?

09.05.2020

Priorities for academic organisations in industry-academic partnerships – COVID-19 and beyond

07.05.2020

Takeda revokes Roche patent to glycosylation pattern extending to Entyvio

07.05.2020

Brexit is upon us – what does it all mean?

06.05.2020

Fiona Nicolson launches three briefings, written by LESI, explaining the business of IP

05.05.2020

Functional claims approved in principle as basis for SPCs

04.05.2020

In response to COVID-19, the European Commission resurrects comfort letters

04.05.2020

Bristows promotes two new partners to its transactional practice

04.05.2020

European Commission resurrects comfort letters to combat COVID-19

01.05.2020

Medical Research Council’s guidance on identifiability/ anonymisation

01.05.2020

How COVID-19 has impacted the adtech industry

29.04.2020

CLIP of the month: Could patent pools help combat coronavirus?

28.04.2020

How is COVID-19 impacting competition law for the UK pharma sector?

23.04.2020

MDR postponement staves off Swixit – for now

22.04.2020

Government agrees to indemnify companies manufacturing ventilators for use by the NHS against IP infringement and product liability

17.04.2020

Government updates ventilator challenge minimum specifications in response to new COVID-19 clinical information

17.04.2020

Moving on from consent? The legal ground for disclosing transfers of value to HCPs

17.04.2020

Coronavirus: what impact is it having on current IT & technology transactions?

16.04.2020

COVID-19 and its impact on Competition Law for the UK pharma sector

14.04.2020

Disputes over FRAND licensing in the automotive sector shift up a gear

09.04.2020

Arrow declarations – How broad can they be?

03.04.2020

Bristows to sponsor and host the first OpenUK Awards

01.04.2020

UK and Europe back exemptions – more medical devices and PPE in the COVID-19 fight

31.03.2020

Smoother sailing for sanitisers

31.03.2020

12 notified bodies now designated under MDR

30.03.2020

CLIP of the month: Indispensability as a test for abuse?

27.03.2020

Commission delays MDR by 12 months

26.03.2020

UK announce new ventilator requirements in the fight against COVID-19

26.03.2020

Want to navigate the FRAND landscape? Bristows launches a free online database of judgments in the English Courts

24.03.2020

French Competition Authority imposes its largest ever fine on Apple for anticompetitive practices

19.03.2020

Medical Devices – When is a change significant?

16.03.2020

Excessive? Unfair? Court of Appeal reaffirms United Brands excessive pricing test

11.03.2020

CLIP of the month: EU Commission unveils plans for ‘digital transformation’ and AI

02.03.2020

Merchandising Monsters – European Commission imposes €14.3 million fine on NBCUniversal

26.02.2020

New regulatory requirements on outsourcing service providers?

14.02.2020

CBD – Could be done for?

13.02.2020

Coronavirus; the growing threat to the global pharmaceutical supply chain

10.02.2020

Transatlantic echoes: FTC and FDA focus on competition in biologics

07.02.2020

Competition between generics and originators – what’s the relevance of a patent?(Part II)

03.02.2020

Competition between generics and originators – what’s the relevance of a patent? (Part II)

03.02.2020

CLIP of the month: A simple model of mergers and innovation

03.02.2020

First Brexit, now Swexit?

03.02.2020

Competition between generics and originators – what’s the relevance of a patent?

27.01.2020

Competition between generics and originators – what’s the relevance of a patent?

27.01.2020

Bristows further expands its leading Life Sciences practice with latest partner hire

27.01.2020

UK merger review developments to look for in 2020

17.01.2020

Searching for trouble? Assessing the CMA report on online platforms and digital advertising

13.01.2020

Medtech Europe calls on EU institutions to speed up MDR implementation

13.01.2020

Grace period for up-classified Class I medical devices receives green light at European Parliament

19.12.2019

Bristows’ Technology practice continues to grow with Alex Keenlyside hire

16.12.2019

Good news for manufacturers of up-classified Class I medical devices

04.12.2019

International tax challenges in a ‘digital world’

02.12.2019

Medical devices: Updates galore!

22.11.2019

Person Responsible for Regulatory Compliance – The confusion continues

20.11.2019

Gene editing – A survey of public opinion

20.11.2019

The European banking authority has published new outsourcing guidelines

14.11.2019

Regulatory enforcement action against Raphaels Bank for IT failures – key points for FS firms and tech suppliers

13.11.2019

Hannah Crowther and Annsley Merelle-Ward awarded UK Rising Star title

09.11.2019

UK court concludes it has no jurisdiction over Vestel’s claim for FRAND determination

05.11.2019

Supreme Court awards employee inventor £2 million compensation for his “outstanding” invention

04.11.2019

FinTech evolution brings both risks and opportunities for traditional tech suppliers

31.10.2019

CLIP of the month: Is a new framework needed to assess antitrust risk?

28.10.2019

Nesta Talks: ‘How to Grow a Human’, with Philip Ball

24.10.2019

Deciphering Rule 11: New guidance on the classification of software medical devices under the EU MDR

18.10.2019

GSK’s passing off claims dismissed

16.10.2019

CLIP of the month: FTC v. Qualcomm on the duty to deal, price squeezes, and exclusive dealing

02.10.2019

Want to look like Kylie Jenner? Well, you probably can’t, says the ASA

25.09.2019

Medical devices: An encouraging September

20.09.2019

Licensing programme terms attract Commission scrutiny

02.09.2019

CLIP of the month: A simple model of mergers and innovation

28.08.2019

Thinking outside the box

14.08.2019

Tech contracts – “Why won’t you just comply with the law?!”

09.08.2019

Going with the Flow(downs)

31.07.2019

CLIP of the month: focussing on the UK generics industry

30.07.2019

NO-tified Bodies? UL UK ceases Medical Devices Directive operations

11.07.2019

French Competition Authority saddles Bikeurope with €250,000 fine

09.07.2019

Interim measures are back – Broadcom faces EC probe

01.07.2019

Orphan designation: the General Court clarifies the meaning of significant benefit

25.06.2019

Killer acquisitions: the CMA and the iZettle/Paypal merger

21.06.2019

Another one bites the dust…

20.06.2019

Fiona Nicolson appointed President of LESI, the global intellectual property organisation

19.06.2019

Lloyd’s pulls out of the EU MDR/IVDR race

13.06.2019

Notified Bodies: eyes on the up-line

04.06.2019

TÜV SÜD gets the Greenlight on EU MDR

23.05.2019

Killer acquisitions and data access or divestment as a merger remedy

14.05.2019

Annsley Merelle Ward named one of the top 20 Trailblazer by World IP Review

02.05.2019

Bristows’ Commercial and IP Transactions practice gains new partner with promotion of Claire Smith

01.05.2019

New Commission interventions target geo-blocking via technical measures and blocking of innovation

12.04.2019

PanOptis takes on Apple, Vestel issues antitrust litigation against HEVC patent pool, injunction granted against ZyXEL

03.04.2019

Just (Don’t) Do It – Commission fines Nike €12.5 million for restricting cross-border sales

02.04.2019

CLIP of the month: The Bundeskartellamt’s Facebook Decision and the intersection of competition law and data protection

28.03.2019

Medical Devices and No-Deal Brexit: where are we now?

20.03.2019

Final credits roll on the Hollywood movies pay-TV saga

19.03.2019

Chancellor’s Spring Statement: Digital Advertising Market Study

13.03.2019

OxFirst’s Third IP and Competition Forum: Creating the Missing Link in the Digital Economy

13.02.2019

NICE releases Evidence Standards Framework for Digital Health Tech

12.02.2019

New guidance on the use of personal data in clinical trials

11.02.2019

The General Court’s judgment in Krka – some welcome clarity over licensing in the context of patent settlements

08.02.2019

The General Court’s judgment in Krka – some welcome clarity over licensing in the context of patent settlements

01.02.2019

Record investment in UK biotech

31.01.2019

3rd Annual W@Competition Conference

31.01.2019

Sophie Lawrance in The Lawyer Hot 100

29.01.2019

CLIP of the month: Competition law and innovation – where do we stand?

29.01.2019

Matt Hancock sets out the UK’s 20-year vision on tackling antimicrobial resistance

28.01.2019

Bristows’ life sciences regulatory practice continues to grow

18.01.2019

High Court rejects application to discharge CMA search warrant

17.01.2019

CRISPR gene editing technology and its many applications

10.01.2019

A brief history of UCART-19

08.01.2019

Cryptography, PKI, Blockchain, Privacy & Trust

08.01.2019

Canal+ finds copyright is no match for the EU single market

18.12.2018

More Impact Online”: The ASA looks to the future with strengthened focus on regulating online ads and the potential use of machine learning to aid regulation

13.12.2018

Partial annulment of Servier decision by the General Court – some good news for pharma innovators at last

12.12.2018

Partial annulment of Servier decision by the General Court – some good news for pharma innovators at last

12.12.2018

New EU Regulation for Veterinary Medicinal Products

11.12.2018

What is the best response to higher prices in the pharma sector?

05.12.2018

Maintaining competition in online advertising: the US FTC’s 1-800 Contacts decision

04.12.2018

CLIP of the month: What is the best response to higher prices in the pharma sector?

04.12.2018

Maintaining competition in online advertising: the US FTC’s 1-800 Contacts decision

27.11.2018

CAR-T round-up: off-the-shelf challengers and avoiding the (cytokine) storm

23.11.2018

European Parliament Considers Use Cases for Blockchain Technology

15.11.2018

US District Court confirms that Qualcomm must offer RAND SEP licences to rival chipset manufacturers

14.11.2018

“One Medicine” – A new approach to healthcare?

06.11.2018

Ethics and Data Privacy

05.11.2018

Brexit and Competition Law: CMA publishes guidance on its role in a “no-deal” scenario

05.11.2018

The Digital Services Tax

01.11.2018

Bristows gets double mention in The Times Best Law Firms 2019

30.10.2018

One more piece in the SPC puzzle – Medical devices with ancillary substances do not qualify for an SPC

30.10.2018

Data protection and information security in EU, India and California – what next?

30.10.2018

CLIP of the month: Does orphan drug pricing pose an antitrust problem?

29.10.2018

Intro to equity investments and transaction structure

26.10.2018

Fighting antimicrobial resistance – overall sales of antimicrobials for use in food-producing animals drops in the EU according to the EMA report

25.10.2018

Venture debt

24.10.2018

Unwired Planet v Huawei: Court of Appeal upholds Birss J’s judgment

24.10.2018

Convertible loans

23.10.2018

Overview of SEIS and EIS

22.10.2018

SEP holders’ guidelines on IoT /5G FRAND licensing

22.10.2018

Polish Plant Protection Products: CJEU confirms Commission was right to reject investigation

20.10.2018

Global FRAND issues unpicked in Japan Patent Office’s new licensing guidance

16.10.2018

Bristows’ Data Protection practice keeps growing with Marc Dautlich hire

04.10.2018

Request to re-open Glaxo ‘dual pricing’ case rejected by General Court: The end of the road for challenges to dual pricing?

04.10.2018

Request to re-open Glaxo ‘dual pricing’ case rejected by General Court: The end of the road for challenges to dual pricing?

04.10.2018

CLIP of the month: Strengthening Buyer Power as a Solution to Platform Market Power?

02.10.2018

Amazon Marketplace seems to be the Commission’s next big data antitrust target

21.09.2018

CAR-T gets the green light in Europe

20.09.2018

The cartelization of innovation – a new emissions scandal?

20.09.2018

Summer FRAND developments: some big antitrust news to come

17.09.2018

BEIS notice on competition law in the event of a ‘no deal’ Brexit

14.09.2018

The Ping judgment – CAT confirms that internet sales ban is restrictive of competition ‘by object’

12.09.2018

Big Data? No antitrust problem for Apple/Shazam

10.09.2018

A constellation of IP stars at Bristows

05.09.2018

Bristows partner Pat Treacy named Deputy High Court Judge

04.09.2018

Competition law challenge to orphan drug prices in the Netherlands

30.08.2018

Are organisms that are the product of mutagenesis subject to the GMO Directive on deliberate release?

20.08.2018

Concordia and the CMA – a drama in (at least) three parts

14.08.2018

Different types of CAR-T

14.08.2018

Concordia and the CMA – a drama in (at least) three parts

14.08.2018

Online advertising – Government acknowledges challenges ahead for competition law

06.08.2018

The EMA’s clinical data publication policy: 1 year on

30.07.2018

Pharma stock management – nothing extraordinary in limiting parallel trade?

28.07.2018

Commission considers pricing algorithms in fining consumer electronics manufacturers for RPM

27.07.2018

Coty gets green light for online platform ban

16.07.2018

MasterCard and Visa MIFfed as the Court of Appeal considers two-sided markets, SCOTUS itself is two-sided (Part 2 – the USA)

13.07.2018

Bristows awarded by enei for its agile working policy

12.07.2018

MasterCard and Visa MIFfed as the Court of Appeal considers two-sided markets, SCOTUS itself is two-sided (Part 1 – the UK)

12.07.2018

European Commission sets up SEP Licensing Expert Group

09.07.2018

Funding for UK research and innovation post-Brexit: Hope on the Horizon?

06.07.2018

CJEU follows Advocate General’s Opinion to confirm the scope of the Specific Mechanism

04.07.2018

CAR-T keeps driving forward: a round-up of recent scientific and commercial developments

03.07.2018

Bienvenue à Bruxelles! Bristows’ Competition and Regulatory teams visit the new Continental Base

02.07.2018

A question of privilege: an insight into EU privilege for UK lawyers post-Brexit

28.06.2018

The CAT sets a clear framework for excessive and unfair prices in its Pfizer/Flynn judgment

20.06.2018

CAT judgment in Pfizer/Flynn: Was the CMA ‘unfair’ in its assessment of Pfizer and Flynn’s prices?

14.06.2018

Drafting leases for life sciences

13.06.2018

Driving immunotherapy forward: More than CAR-Ts

08.06.2018

FRAND in the UK (May 2018 edition): Unwired Planet appeal, Apple v Qualcomm

24.05.2018

The UK AIPPI Council awards Sarah Blair with prize

21.05.2018

Depression Delayed: CMA’s paroxetine pay-for-delay case heads to Luxembourg

14.05.2018

Can’t stop the CAR-T

09.05.2018

The NHS gets on the bandwagon with CAR-T

09.05.2018

Real estate practice gains new partner with Tim Allen’s promotion

02.05.2018

The CJEU guidance in MEO on price discrimination in licensing may also impact FRAND / SEP licences

25.04.2018

Advertising in the digital age – the future role for competition law

20.04.2018

How the life sciences industry may be affected by Brexit

05.04.2018

‘Baysanto’: EU merger clearance of the Bayer/Monsanto confirms continued attention to innovation markets

28.03.2018

Race to publish rival SEP, FRAND Codes of Conduct: new CEN-CENELEC working groups established

22.03.2018

Data Protection Update

17.03.2018

Depression delayed: CMA’s paroxetine pay-for-delay case heads to Luxembourg

15.03.2018

The BKA’s Facebook investigation: new frontier or regulatory overreach?

08.03.2018

Side CAR-Ts

07.03.2018

CLIP of the month: Competition restraints in online sales after Coty and Asics – what’s next?

28.02.2018

CAR-T rolls on

20.02.2018

Different types of value transfer in ‘reverse payment’ settlement agreements

16.02.2018

The competition law issues of the CRISPR patent pool

16.02.2018

The competition law issues of the CRISPR patent pool

16.02.2018

AG Opinion: Organisms obtained by mutagenesis are GMOs exempt from the provisions of the GMO Directive

09.02.2018

Specific Mechanism applies to extended SPC period opines AG Tanchev

09.02.2018

Excessive pricing spreads to Denmark – a cautionary tale about exclusive licensing

08.02.2018

Proposal to extend UK withholding tax on royalties – The start of a major shift in the UK’s approach to taxation?

06.02.2018

10 key points on Parallel Trade and Pharma

29.01.2018

The chips are down! The Commission fines Qualcomm for abuse of dominance

26.01.2018

Evolving how English courts construe written commercial contracts (Teva v AstraZeneca)

24.01.2018

Misleading information and competition law – Case C-179/16 CJEU Judgment of 23 January 2018 (Avastin/Lucentis –Italy)

24.01.2018

Licensing commitments sufficient for Qualcomm to secure NXP takeover green light

24.01.2018

Impact of Brexit on International Data Transfer Mechanisms

17.01.2018

Patents Court rules on non-invasive prenatal diagnosis patents

12.01.2018

French competition authority fines pharma company for its anti-generic ‘commando’ sales tactics

11.01.2018

Sandoz v Amgen: An update

09.01.2018

Online sales bans in the sports equipment sector: the CMA’s Ping decision

09.01.2018

USA v. UK – a united approach to FRAND? Comparing the new judgment in TCL v. Ericsson with Unwired Planet v. Huawei

08.01.2018

Digital Health – The CJEU’ s first decision on standalone software as a medical device

14.12.2017

In a froth: Trademark licensing fails to disguise anti-competitive market sharing arrangement

14.12.2017

Biotech Review

13.12.2017

UK Government announces a Life Sciences Sector Deal as part of its Industrial Strategy

06.12.2017

Third-party platform bans justified for genuinely luxury brands

06.12.2017

NHS Pharmaceutical Procurement – Top 10 Tips

05.12.2017

Pharma Sector Inquiry ‘Encore’

29.11.2017

Commission Communication on SEP Licensing – where has the Roadmap led?

29.11.2017

GDPR and Data Processing Agreements

28.11.2017

Deciding on terms of privacy policies – what are the risks of anti-competitive collusion?

28.11.2017

Dutch Health Council’s proposal of compulsory licensing as solution to high pharma prices

27.11.2017

Lifting restrictions on veterinary medicine retail channels and veterinary practice ownership in Europe (Case C-297/16)

24.11.2017

Smart buildings and data protection

24.11.2017

EU reaches agreement to end unjustified geoblocking

24.11.2017

EU Reaches Agreement to End Unjustified Geoblocking

23.11.2017

French Pharma – French Competition Authority launches new sector enquiry

23.11.2017

Providing Misleading Information About Product Safety – a Restriction of Competition by Object?

21.11.2017

Economical with the truth? When providing misleading information to authorities might be an object infringement

20.11.2017

Bristows to open first international office in Brussels

17.11.2017

Current legal trends in Robotics and Autonomous Systems

14.11.2017

Product hopping: The competition law risks of launching new product formulations

14.11.2017

Introducing On the Pulse – the Bristows life sciences microsite

13.11.2017

Dosage Regimen Patent Held Invalid

09.11.2017

Bristows ranked highly in the legal directories

08.11.2017

Is there such a thing as Substitution or Interchangeability for Biosimilars?

08.11.2017

Artificial Intelligence: the evolving legal landscape – and what businesses need to do to comply

08.11.2017

Product hopping: The competition law risks of launching new product formulations

01.11.2017

CRISPR undergoes exciting new developments

31.10.2017

Arrow declarations post Actavis v Eli Lilly

27.10.2017

Construction and novelty post Actavis v Eli Lilly

27.10.2017

Unjustified Threats Act comes into force

27.10.2017

Artificial Intelligence: how to manage the risks in applying AI

27.10.2017

Brucellosis Vaccine Prize

26.10.2017

SEPs, 5G and the IoT: where will the Commission land on use-based licensing?

25.10.2017

Artificial Intelligence: some practical risks, challenges and limitations in applying AI

24.10.2017

CAR-T Therapy: the current landscape

19.10.2017

Excessive Pricing – Pfizer/Flynn in light of the CJEU’s recent decision

17.10.2017

Artificial Intelligence: an introduction to our series on AI and the law

17.10.2017

Laitenberger on the notions of fairness and consumer welfare in EU Competition Law

16.10.2017

London Tech Week 2017: Connected Autonomous Vehicles event (Full video)

12.10.2017

EU Commission issues guidance to online platforms for tackling illegal content online

10.10.2017

Managing Intellectual Property IP Stars 2017

05.10.2017

Biosimilars: NHS approach to procurement

02.10.2017

European Court says scientific proof of causation is not required under the EU Product Liability Directive

02.10.2017

Standardisation agreements in pharma – Competition law tips for collaboration between pharma companies

02.10.2017

Liz Cohen appointed JMP, Greg Bacon and Gemma Barrett promoted partners

28.09.2017

Are pharmaceutical companies using rebates at risk of being investigated by the competition authorities?

25.09.2017

UK competition enforcement in the Pharma sector: A priority area for the CMA

25.09.2017

Proposed EU Regulation for the free flow of Data in the European Union

25.09.2017

Bristows lawyers recognised in Experts Guides: Women in Business Law 2017

20.09.2017

EPO takes an ‘about turn’ on the patentability of products obtained by essentially biological processes

20.09.2017

FDA approves first GM individualised cell therapy

20.09.2017

Supreme Court “improves” upon the Improver/Protocol Questions in Actavis v Eli Lilly

20.09.2017

The lure of the US for UK biotech

20.09.2017

Licensing of Latvian collecting society prompts CJEU to provide greater clarity on how to determine excessive pricing

18.09.2017

Clustering and Innovation Districts

14.09.2017

Can UK Data Protection Law be made Brexitproof?

14.09.2017

How to use Legitimate Interests legitimately?

13.09.2017

CRISPR-Cas9 – An update

08.09.2017

The CJEU’s Intel judgment – First thoughts and some predictions

06.09.2017

Apple’s battle with Qualcomm spreads to the UK

01.09.2017

Free movement of health data and data protection implications

25.08.2017

UK publishes cyber security framework

15.08.2017

The use of mobile apps and software as a form of healthcare within the NHS

14.08.2017

The ICO’s approach to consent under the GDPR and how it relates to digital health

10.08.2017

Excessive Pricing: Aspen lose their appeal in Italy – and are in the Commission’s crosshairs

07.08.2017

Data protection updates – 20 July 2017

20.07.2017

London Tech Week 2017: Connected Autonomous Vehicles event (highlights)

17.07.2017

Innovation and merger control

10.07.2017

Incident Response Plans

07.07.2017

Draft Spanish Data Protection Law

03.07.2017

Bristows wins Competition Team of the Year at The Lawyer Awards 2017

29.06.2017

Neuro technology and the right to mental privacy

27.06.2017

Luxury brands, third party platforms and EU competition law – guidance from AG Wahl

26.06.2017

A FRAND torpedo? An update on Vodafone v Intellectual Ventures

24.06.2017

Antitrust authorities are increasingly interested in pricing algorithms

23.06.2017

Bristows shines in latest IAM Patent 1000

13.06.2017

When are legitimate interests legitimate?

12.06.2017

Online auction commitments demonstrate digital markets are central to CMA’s priorities

11.06.2017

GDPR: Legal facts and a call to action

07.06.2017

Unwired Planet v Huawei: a new FRAND injunction

07.06.2017

Data Protection codes of conduct hitting the fast lane under GDPR

31.05.2017

Connected TV World Summit 2017

30.05.2017

Respecting Privacy, Safeguarding Data and Enabling Trust

24.05.2017

The Commission steps into the excessive pricing arena

23.05.2017

Transparency may undermine online competition: Commission’s Final Report on the E-commerce Sector Inquiry

23.05.2017

Bristows works on sale of Kodak Industrial Complex in Harrow

11.05.2017

Case Analysis: Elisabeth Schmitt v TUV Rheinland LGA Products GmbH

09.05.2017

Bristows expands disputes practice with promotion of Angela Fouracre to partner

04.05.2017

Patent licensing: 5G & the Internet of Things

24.04.2017

How the CJEU has interpreted “protected” in the SPC regulation

21.04.2017

The role of the DPO

21.04.2017

Unwired Planet v Huawei: Is FRAND now a competition law free zone? Not so fast…

20.04.2017

Excessive pharma pricing

18.04.2017

Patent Review of the Year

12.04.2017

Database protection and the impact of Brexit

11.04.2017

Building a Data Economy: With new rights might come a new obligation to license

10.04.2017

Unwired Planet v Huawei: the key points

05.04.2017

Unwired Planet v Huawei: UK High Court determines FRAND licence rate

05.04.2017

Clinical trial data transparency: the EU inches closer to legal certainty

04.04.2017

EU Commission’s Microsoft/ LinkedIn Decision – watershed for competition and data?

31.03.2017

GDPR and data breach requirements

28.03.2017

What is my personal data worth? – Commoditised data as “counter performance”

28.03.2017

Bristows wins TMT Team of the Year at Legal Business Awards 2017

24.03.2017

Nine-strong Trade Marks and IP disputes team to join Bristows

21.03.2017

Will pricing algorithms be the European Commission’s next antitrust target?

21.03.2017

Second medical use issues—where are we now and where should we be going?

15.03.2017

Collusion in the online economy – new competition law traps for the unwary?

08.03.2017

Pay-for-delay focus on steroids

07.03.2017

GDPR and Data Processors

27.02.2017

The Emperor’s New Clothes? The Commission opens three e-commerce competition investigations

24.02.2017

Should we rely on automated decision making technologies?

24.02.2017

Landmark court case serves as a useful reminder of CCTV compliance

20.02.2017

eSports: brand opportunities, legal considerations & the future

16.02.2017

Significant changes to Japanese data protection law

15.02.2017

Back to the future: the Commission opens e-commerce competition investigations

15.02.2017

Insuring Driverless Cars

13.02.2017

Copyright in the digital single market – harmony and disharmony for copyright exceptions

13.02.2017

2016/17: Data Protection Top 10

13.02.2017

CCTV, drones and surveillance

13.02.2017

Data protection in UK (England and Wales): overview

13.02.2017

Privacy breach damages: High Court provides some insight

13.02.2017

Data privacy case law round-up

10.02.2017

Data Protection in 2017

08.02.2017

NICE and NHS England Consultation on proposals for changes to the evaluation and funding of drugs

07.02.2017

The compliance of EU-US data transfers faces another legal challenge

07.02.2017

Data privacy partner Robert Bond joins Bristows

01.02.2017

Opening Life Sciences’ Unified Patent Court war chest

26.01.2017

Privacy in UK (England and Wales): overview

26.01.2017

Amazon’s E-Books antitrust saga – War now Peace?

25.01.2017

Public Procurement Regimes in the UK and EU

24.01.2017

First CMA competition decision on excessive pricing in the pharmaceutical sector

23.01.2017

Patent licensing and antitrust – Qualcomm in the firing line

23.01.2017

FTC settles abusive acquisition of pharma licensing rights

23.01.2017

The Research and Development Block Exemption (RDBE)

18.01.2017

European Parliament considers regulatory regime for Robotics and AI

17.01.2017

Compulsory Licencing: the Brave New World for (non-personal) data in Europe?

17.01.2017

Compulsory Licencing: the Brave New World for (non-personal) data in Europe?

17.01.2017

Science in architecture – the opportunities and challenges

16.01.2017

A decision of Paramount importance to independent film financing…?

22.12.2016

The vexed question of the appropriate ‘royalty base’ for FRAND-based damages – the US Supreme Court declines to answer

15.12.2016

A Brief Introduction to Adblockers

13.12.2016

When the price isn’t right – CMA fines Pfizer / Flynn for excessive pricing

13.12.2016

We need to talk…about Pharmaceuticals and Standard Essential Patents

07.12.2016

Brexit and copyright law: will the English courts revert to the ‘old’ test for originality?

06.12.2016

An introduction to Adblockers for lawyers

05.12.2016

Hear it here first – competition law updates…

01.12.2016

Copyright in the digital single market – a fairer and sustainable marketplace?

29.11.2016

Copyright in the digital single market – fair remuneration for artists?

29.11.2016

Data Subject Access Requests

27.11.2016

The Institute of Trade Mark Attorneys become Chartered today

24.11.2016

Brexit: Why the Court of Justice may yet have a role to play…

24.11.2016

Premier League scores in latest dispute with pub broadcasting football matches

16.11.2016

High Court Rules in Article 50 Case

04.11.2016

Richard Pinckney promoted to Bristows’ Partnership

01.11.2016

Marek Petecki named Bristows’ new Joint Managing Partner

01.11.2016

Modernising EU legislation for medical devices: the new Medical Devices Regulation

30.10.2016

A sense of relief: enforcing second medical use patents

28.10.2016

Arrow declarations – a second shot at the target

26.10.2016

First Borderline Decision of the EU Commission: Is this a welcome approach for industry?

26.10.2016

A bluffer’s guide to Brexit models

26.10.2016

Resetting Competition Policy Frameworks

26.10.2016

Actavis v ICOS – clearing the way between a rock and a hard place?

25.10.2016

Can you obtain an SPC for a new formulation of a medicine? The UKIPO considers the CJEU decisions in MIT and Neurim

25.10.2016

Term sheets in equity investments (from a company’s perspective)

25.10.2016

Electronic cigarettes: the medicine of tomorrow?

24.10.2016

Lyrica continues – The Court of Appeal considers infringement and validity of Pfizer’s second medical use patent

24.10.2016

Painfully objective decision of the Court of Appeal in Warner Lambert v Actavis tortuously applied by the Patents Court

21.10.2016

Excessive pricing: the Italian version

19.10.2016

The European Commission’s E-commerce Conference

18.10.2016

E-Commerce Sector Inquiry: Digital Content

13.10.2016

Robotics and law: Key legal and regulatory implications of the robotics age (Part II of II)

07.10.2016

Competition defences, patent litigation and costs…

07.10.2016

The privacy/ competition law overlap: new competition rules on big data?

03.10.2016

Collaborate to accumulate: exciting commercial collaborations in the medical devices sector

30.09.2016

The privacy/ competition law overlap: co-operation between enforcement agencies?

27.09.2016

Patent Licensing and the Internet of Things – a Solution?

22.09.2016

E-Commerce Sector Inquiry: Digital Content

20.09.2016

Copyright Across Borders: Bitesize summary of the EC communication on copyright

16.09.2016

EU Court to rule on ability of luxury brand owners to control online distribution

16.09.2016

Competition and Regulation in Digital Markets

16.09.2016

Connecting the DSM dots

15.09.2016

New guidelines on EU net neutrality: a force to BERECkoned with

09.09.2016

BEREC addresses adblocking and zero-rating with net neutrality implementation guidance

08.09.2016

Breaking news – General Court confirms Lundbeck decision and fine

08.09.2016

Brexit won’t shift UK privacy law in short-term

05.09.2016

Bristows hires Anna Cook as partner in the Commercial and Technology Disputes team

31.08.2016

Proposed changes to the US Antitrust Guidelines for the Licensing of Intellectual Property – a transatlantic perspective

22.08.2016

Online poster seller in the frame for algorithm-centred price-fixing cartel

16.08.2016

This summer’s (not so) light reading – the CMA’s published Paroxetine decision (GSK/generics)

12.08.2016

Competition policy v IP: striking a balance is a tricky exercise

05.08.2016

So what does Brexit mean for copyright (and database rights) in the UK?

05.07.2016

Brexit – What it means for competition law? Q&A …

28.06.2016

Brexit – What Next? A competition law perspective

27.06.2016

That’s a wrap! The European Commission accepts Paramount’s pay-TV commitments

27.06.2016

Brexit – what next? A competition law perspective

27.06.2016

FRAND in Finance

25.06.2016

European Commission’s E-commerce Sector Inquiry: A summary of its preliminary findings on Goods

19.06.2016

Testing the patent pool waters

15.06.2016

Hilary Jones joins Bristows

14.06.2016

Vodafone v Intellectual Ventures – Is a new front about to open in the FRAND wars?

13.06.2016

Time to modernise standards?

06.06.2016

May Day! Competition policy: trade war by other means?

03.06.2016

Stephen Smith joins Bristows Competition team

23.05.2016

Qualcomm in the firing line again

23.05.2016

Court of Appeal provides guidance on determining an account of profits

17.05.2016

Life Sciences under the GDPR

17.05.2016

The Commission has seen the future and it is standardised!

12.05.2016

More on mythical creatures – FRAND and hold up revisited

09.05.2016

Keeping a weather eye on competition and innovation

03.05.2016

Recent pay-TV developments: the dawning of a new era?

27.04.2016

Sophie Lawrance promoted partner

26.04.2016

The CMA still has pharma and medical devices in its sights

22.04.2016

UPDATE: International spring cleaning time to review those IPR Guidelines

20.04.2016

The NHS opens up to increased competition

18.04.2016

A relatively rare beast: CMA clearance of a pharmaceutical sector merger

14.04.2016

International spring cleaning: time to review those IPR guidelines…

01.04.2016

Competition law no bar to patent licence royalties

18.03.2016

Digital Single Market – geo-blocking of digital content

18.03.2016

A week of standard setting conferences – Part II, the London Leg

03.03.2016

A week of standard setting conferences – part 1: FRAND, hold-up and other mythical creatures

01.03.2016

Standards, standards everywhere

29.02.2016

New technology and competition law – mapping the way

26.02.2016

Algorithmic agony? The perils of platform T&Cs

22.02.2016

Antimicrobial resistance – a global threat triggering a global response

18.02.2016

CMA’s mood boosted over fines for anti-depressant

12.02.2016

Regeneron Pharmaceuticals Inc v (1) Kymab Ltd (2) Novo Nordisk A/S

08.02.2016

The Commission’s consultation on the IP Enforcement Directive – a competition as well as an IP issue

08.02.2016

Germany’s competition probe into Facebook’s T&Cs, precedent or outlier?

04.02.2016

The Commission’s 2016 Competition Enforcement Priorities: the Digital Economy and Standard Essential Patents

03.02.2016

Peripheral Decisions in the Lyrica (pregabalin) Saga

26.01.2016

Plausibility in immunotherapy – is PD-1 the way forward?

22.01.2016

Why a Spanish state aid decision is making EU governments nervous

22.01.2016

Is ‘big data’ the new frontier for competition law?

20.01.2016

Has the CJEU paved the way for parallel importation of veterinary medicines by livestock farmers (Case C-114/15)?

12.01.2016

Loyal to investigating pharma product discounts? – New CMA investigation

21.12.2015

New industry coalition established to promote FRAND licensing

10.12.2015

US Court guidance on principles to apply for RAND royalty calculations

10.12.2015

UK – Mylan v. Warner-Lambert/Abuse

09.12.2015

6th Report on the Monitoring of Patents Settlements – déjà vu?

09.12.2015

UK – Actavis v. Eli Lilly

07.12.2015

Approaches to Drugs Going Off-Patent: Naughty or NICE?

02.12.2015

#EUhaveyoursay

26.11.2015

Analogue taxis and hotels beware! The EU Internal Market Strategy is published

12.11.2015

CMA investigates pharmaceutical sector pricing issues

05.11.2015

Nokia / Alcatel-Lucent’s SEP portfolio: A tale of two mergers

02.11.2015

Huawei v ZTE – three months on

29.10.2015

One step closer to decoupling veterinary medicines from the human medicines legislation

21.10.2015

Online platforms hold on tight

20.10.2015

“Everything online” including “everything copyright”

15.10.2015

Competition law as panacea for high prices?

12.10.2015

Huawei may not be the end of the story

15.09.2015

No rest for the Commission

08.09.2015

Interested in competition law developments in the pharma sector…?

04.09.2015

Flynn, Pfizer and Pharma in the Frame

27.08.2015

Product-hopping prohibited – Actavis’s most recent brush with US antitrust

18.08.2015

Digital markets, DG Comp’s policy on data / privacy and some crystal-ball gazing

06.08.2015

Geo-blocking and the Single Digital Market: a new statement of objections

31.07.2015

CJEU judgment in Huawei v ZTE (Case C-130/13): theory and practice (2: Practice)

27.07.2015

CJEU judgment in Huawei v ZTE (Case C-130/13): theory and practice (1: Theory)

27.07.2015

The unseen risks of e-commerce – a timely AG opinion on technical measures for breaching the competition rules

22.07.2015

A sympathetic Australian approach to life cycle management and recent CMA guidance on Pharma sector rebates

16.07.2015

The e-Commerce sector inquiry gets under way

15.07.2015

Salt limitation leads to sweet and sour Court of Appeal judgment

07.07.2015

Non-challenging times…

11.06.2015

CJEU confirms the broad scope of Article 6 of the Transparency Directive

18.05.2015

English High Court considers infringement of second medical use claims

18.05.2015

The EFTA Court provides an Advisory Opinion on the validity and scope of SPCs for veterinary medicinal products

18.05.2015

Try before you buy: pre-action disclosure of licences

29.04.2015

European Commission announces e-commerce sector inquiry

23.04.2015

New DG Connect Guidelines on interoperability information – shedding some light on the vexed question of IP valuation

10.04.2015

UK Supreme Court ruling on standard of review for CAT appeals in 08x numbers case

02.04.2015

Enacted: Consumer Rights Act 2015

30.03.2015

Tax issues for Tech start-ups

13.03.2015

Sticky switching opens the way to over-stickering

12.03.2015

German Federal Cartel Office (FCO) decision in HRS (online hotel booking)

02.03.2015

Fast track CAT injunctions – have your say on the draft rules

26.02.2015

No invention in setting a research project and claiming the results

24.02.2015

The published Lundbeck decision – first impressions (with some facts, a little law and three remarkable points)

23.02.2015

Companies ShrIEEEk at new SSO bylaws

19.02.2015

Smith & Nephew v ConvaTec No 2: a well rounded performance

04.02.2015

Surveillance Technologies and Privacy: Automatic Number Plate Recognition

02.02.2015

Warner-Lambert/Actavis – Competition Law Insights

02.02.2015

Amended claims must not be obvious or arbitrary

26.01.2015

New UK “Google Tax” on Diverted Profits

23.01.2015

(Bio-)Similar views?

19.01.2015

Chinese MIIT identifies basis for a FRAND royalty rate

15.01.2015

Resolutions for innovation in 2015

07.01.2015

The Commission’s 5th report on patent settlements – a pretty picture?

24.12.2014

Spanish “Google Tax”

22.12.2014

More on predatory innovation – and innovative Apples…

19.12.2014

SEPs and FRAND: The calculation of RAND royalties in the US – incremental guidance

16.12.2014

With great patents, there must come great restraint (but a bit less in the EU than the US)

05.12.2014

Most-favoured-nation clauses in e-commerce: a guest economist’s view!

28.11.2014

The politics of SEPs – finding the third way to obtain/avoid injunctive relief?

21.11.2014

A barrel of laughs…..

21.11.2014

STOP PRESS – AG Opinion in Huawei v ZTE published today

20.11.2014

Europe’s Unitary Patent system draws one step nearer…

19.11.2014

A (belated) Happy Standards Day!

22.10.2014

Indian competition authority gets in on the IP action

17.10.2014

Eli Lilly v HGS – High court tries to implement CJEU decision regarding SPCs

16.10.2014

The Patents Court confirms that clinical trials are not necessarily confidential

16.10.2014

Commission Decision to increase cooperation with Member States on IP

06.10.2014

Non-challenging reading for the weekend

26.09.2014

Huawei v ZTE: will the CJEU be first past the post on SEP policy….?

23.09.2014

The CJEU serves up a little common sense in Cartes Bancaires?

15.09.2014

“…hard cases make bad law …” – round table discussion on Intellectual Property and Competition

11.09.2014

Nespresso finalises its competition commitments in France – but at what price for innovation?

10.09.2014

Innovation and Intellectual Property – a controversy?”

05.09.2014

Brazil joins the ‘pay-for-delay’ party

29.08.2014

The CMA’s plan for IP

11.08.2014

Year of the Phoenix (aka EU/US competition cases reigniting in China)

06.08.2014

The English Court – the one-stop shop for DNIs across Europe?

31.07.2014

‘Care’-ful with know-how and trade marks

23.07.2014

Competition, innovation and DG Comp – in the mainstream press (or at least the Wall Street Journal)

09.07.2014

Fast track CAT injunctions

26.06.2014

ZTE files competition complaint against Vringo with the European Commission

20.06.2014

Competition law issues in commercial contracts

04.06.2014

Bifurcation at the UPC – competition policy squeezes and the scope for trolls

02.06.2014

Contracting for Agile Software Development

23.05.2014

Competition law & IP licensing agreements

22.05.2014

Recent developments in the TMT sector and competition law

21.05.2014

Reckitt Benckiser reduces its competition law heartache in the UK / takes some of its own medicine

19.05.2014

The revised technology transfer regime: is there more to patents than their validity?

08.05.2014

“Technological predation” – part II

24.04.2014

Another collecting society has competition law concerns…

17.04.2014

Predatory technology – a viable antitrust concept?

14.04.2014

Online advertising restrictions in the spotlight again

03.04.2014

University spin-out merger decision: lessons to be learned

02.04.2014

Object restrictions on the menu

28.03.2014

US judge questions illegality of seeking an injunction

27.03.2014

BREAKING NEWS – New EU Technology Transfer Regulation and Guidelines

21.03.2014

Pay-for-delay: an article on recent-ish developments

19.03.2014

The FRAND debate: is the tide turning?

18.03.2014

Collusion in the standard-setting context – are we likely to see claims in the EU?

17.03.2014

Five interesting things you might not have spotted about Case C-351/12, OSA (AKA the “Czech Spa” case)

12.03.2014

Competition, innovation and IP – a modest proposal

28.02.2014

Divisive divisionals – more on the Consiglio di Stato Pfizer judgment

26.02.2014

Global convergence on pharma deals close to patent expiry

20.02.2014

Consiglio di Stato reinstates Pfizer €10.7 million Xalatan/latanoprost fine

19.02.2014

Teva/Cephalon merger decision – no reason to nod off

18.02.2014

HTC v Nokia (UK) – no case for exhaustion….

17.02.2014

Technology licensing: adapting to the EU’s new regime – update

14.02.2014

Last orders at the OFT…..

13.02.2014

Elevated liability for cartelists?

31.01.2014

“Les génériques dangereuses”: denigration and other recent pharma sector competition issues in France

31.01.2014

Smart tactics in the smartphone war?

30.01.2014

Actavis leaves scope for dissent

30.01.2014

Litigation update

24.01.2014

Reckitt Benckiser still suffering competition law heartache in the UK

17.01.2014

Developments in the CC’s private healthcare market investigation in the UK

16.01.2014

The OFT tackles restrictions on the online availability of medical devices

14.01.2014

Territorial licensing in the spotlight (again)

13.01.2014

New paper on ‘Injunctions for FRAND-pledged SEPs: the quest for an appropriate test of abuse under Article 102’

13.01.2014

Practice notes to note …

07.01.2014

Online (r)evolution: Bosch boshed by the Bundeskartellamt

06.01.2014

On line (r)evolution? The prospects for selective distribution in an internet future

20.12.2013

French Competition Authority fines Schering-Plough for abuse of dominant position

19.12.2013

Find a Patent: Intellectual Venture’s searchable portfolio

18.12.2013

CC investigation: private motor insurance & MFNs

17.12.2013

A step closer to consensus on the availability of injunctive relief for an SEP?

13.12.2013

The General Court dismissed appeal against Commission’s approval of Microsoft’s acquisition of Skype

12.12.2013

Tough times ahead for patent trolls in the US as Innovation Act is passed by House of Representatives

11.12.2013

The 4th Patent Settlement Monitoring Report – what’s new and what’s not?

10.12.2013

Almunia’s speech

09.12.2013

How efficient is the Commission at making decisions under Article 101 (3)?

06.12.2013

Commission turns its attention to online sales

06.12.2013

Another front in the telecoms ‘patent wars’: a novel type of antitrust complaint

06.12.2013

The Commission clears Microsoft/Nokia merger

06.12.2013

IBC Standards and Patents conference

05.12.2013

China has its say in the global F/RAND and SEP licensing debate

03.12.2013

EU authorities coordinate in bringing investigations against Amazon to a close

03.12.2013

High Court grants injunctions against Barclays in a non-FRAND competition case

05.11.2013

Virgin v Zodiac – what implications for the pharma sector?

31.10.2013

Here cometh the CMA …

30.10.2013

Alleged refusal to supply – when are measures against parallel trade abusive?

30.10.2013

Every little bit helps: with luck, the new groceries code adjudicator will effect real change

15.10.2013

US eBooks judgment: a view from across the Atlantic

17.09.2013

Contracts for Start-Ups – The basics

13.09.2013

Digital Copyright – Liability of ISPs

11.09.2013

Maximising privilege in competition law matters

31.05.2013

VIEW:

CJEU Judgment in European Superleague Case has Significant Implications That Go Beyond Football

Other News

CJEU Judgment in European Superleague Case has Significant Implications That Go Beyond Football

Sean-Paul Brankin quoted in PaRR

Podcast: Automated Decision-Making

Implementation deadlines for the EU In Vitro Diagnostic Medical Device Regulation further postponed

Bristows enhances its world class patent litigation practice in Life Sciences and Technology with the promotion of two new partners

UK MDR: further delays, unexpected developments?

Podcast: EDPB guidance on ePrivacy

Competition Law Focus on Healthcare Markets Continues with Welcome (but Limited) CMA Guidance on Collaboration for Combination Therapies

Competition Law Focus on Healthcare Markets Continues with Welcome (but Limited) CMA Guidance on Collaboration for Combination Therapies

Podcast: Children’s Data

The Court of Appeal confirms English courts can force parties into ADR

Stephen Smith quoted in Global Competition Review

AI’s emerging role in cancer diagnosis

Autumn Statement 2023: key business tax announcements

ICO issues draft guidance on transparency in health and social care

Tax Briefing: the Supreme Court’s decisive ruling in HMRC v Vermilion Holdings

Failing faster using AI cannot be considered a success – A round-up of TechBio UK 2023 conference

Human embryo research: should we re-draw the line?

Instagram v Meta 404: Not for the GRAM

Stephen Smith quoted in The Times

GRUR Patent’s August 2023 edition on Plausibility in the UK following Sandoz and Teva v BMS

Naked and Afraid: Intel re-fined €376.3m for naked restrictions

Victoria Yuan quoted in Equity Report on Optum/EMIS

Stephen Smith quoted in Global Competition Review

Every Lidl helps: competition in the groceries sector

‘Tuna bonds’ in Mozambique – Important arbitration decision from the Supreme Court on the proper approach to s.9 of the Arbitration Act 1996

Will Microsoft’s call of duty to restructure Activision deal pay off?

The Innovative Devices Access Pathway – expediting access to MedTech

DHSC consults on statutory disclosure of industry payments to the healthcare sector

First CRISPR therapy seeks regulatory approval, but will it be able to avoid the pitfalls of other cell and gene therapies?

ICO to investigate data security of period and fertility tracking apps

Bristows opens Dublin office

Sham litigation meets competitor denigration: Italian competition authority fines Roxtec for abuse of dominance

Bristows appoints Adrian Sim as new Joint Managing Partner

Can your DPO also act as ‘Senior Responsible Individual’ under the proposed UK Data Protection Bill?

ATVI/MSFT: Victoria Yuan quoted in CTFN

A deep dive on new UK post-market surveillance rules

Dark patterns – where privacy, consumer and competition laws meet

Team NB adopts template tripartite agreement for legacy medical devices

New UK Approved Bodies appointed for medical devices

Royalty payments in patent licensing

Proposed review of the statutory scheme: a sign of things to come in VPAS?

LexisNexis webinar: The future of cookie pop-ups

Is the end near for UKCA marks for medical devices?

Sophie Lawrance quoted in Global Competition Review

Sophie Lawrance quoted in The Times

AI – an issue of ‘national security’?

ATVI/MSFT: Stephen Smith and Victoria Yuan quoted in CTFN

Joe Sako Summer Workshop 2023

The text and data mining copyright exception in the UK “for the sole purpose of research for a non-commercial purpose”: what does it cover?

The CMA puts AI under the microscope

Medicines aspects of Windsor Framework to commence in 2025

Stephen Smith quoted in Global Competition Review

CNIL fines Criteo €40m for adtech breaches

Can you read minds yet? The ICO publishes its report on the use of neurotechnology

The present and future of SESG for biopharmaceutical companies

The New EU R&D Block Exemption and Guidelines – A Partial Win for Innovation!

CLIP of the month: New frontiers for assessing digital mergers. Boldly going where competition authorities have not (quite!) gone before

Victoria Yuan quoted in Equity Report

Anticipating the revised EU Product Liability Directive and the new EU Artificial Intelligence Liability Directive

Proposal for a Regulation for substances of human origin

UK MDR amending legislation heralds arrival of new medical device framework

Sophie Lawrance quoted in Global Competition Review

Open source and sustainability – where’s the gap?

Sophie Lawrance quoted in Global Competition Review

Re-packaging of parallel traded medicinal products

What a time to be (AI)live! What’s next for Generative AI?

Bristows and KPMG co-publish whitepaper on sourcing agile services to deliver digital transformations

DNA sequencing by synthesis patents held valid and infringed

The Digital Markets, Competition and Consumers Bill: 10 things you need to know

Bristows is delighted to announce the promotion of three new partners

CLIP of the month: European Commission draft regulation on SEPs – simplifying or muddling FRAND licensing?

Bristows acts in leading trade mark case

Reasons to be optimistic in 2023

Latest Bristows’ SnippITs article re-published by LexisNexis

TechBio investment scene: two tribes go to war?

Under the antitrust spotlight: (mis)use of patents in the pharma sector